| |
| |
|
| Insider
Information: |
Meyers Michael L. |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,280 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$539,630 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,280 |
|
|
| Total
Value |
$539,630 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 10.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Syndax Pharmaceuticals Inc |
SNDX |
|
2022-01-31 |
23,280 |
2018-10-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2022-01-31 |
4 |
A |
$12.39 |
$21,236 |
D/D |
1,714 |
23,280 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-12-30 |
4 |
OE |
$8.77 |
$51,743 |
D/D |
5,900 |
21,566 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-04-26 |
4 |
B |
$15.46 |
$7,730 |
D/D |
500 |
15,666 |
0.01 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-01-31 |
4 |
A |
$12.00 |
$21,252 |
D/D |
1,771 |
15,166 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2020-07-31 |
4 |
A |
$7.97 |
$21,240 |
D/D |
2,665 |
13,395 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2020-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
10,730 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2019-03-21 |
4/A |
B |
$4.87 |
$39 |
D/D |
8 |
7,230 |
0.01 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2019-03-21 |
4 |
B |
$4.87 |
$5,436 |
D/D |
1,104 |
7,222 |
0.01 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2019-01-31 |
4 |
A |
$4.76 |
$17,707 |
D/D |
3,720 |
6,118 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2018-10-30 |
4 |
B |
$4.79 |
$958 |
D/D |
200 |
2,398 |
0.01 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
